Lupin
Innovation led transnational pharmaceutical company producing a wide range of generic.
Market cap
$11.9b
Enterprise value
$12.3b
Share price
INR1902.50 LUPIN.NS
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
$50.0m | Post IPO Equity | ||
| Total Funding | 000k | ||
| EUR | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 8 % | - | 21 % | 13 % | 15 % | 5 % | 7 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 15 % | 12 % | 21 % | 26 % | 25 % | 24 % | 24 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (9 %) | 3 % | 10 % | 15 % | 16 % | 15 % | 15 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments analysisEdit
Investments by Lupin
Edit
ACQUISITION by Lupin Jul 2015
ACQUISITION by Lupin Jul 2015
ACQUISITION by Lupin Oct 2017
ACQUISITION by Lupin Jul 2015
ACQUISITION by Lupin Jul 2015
ACQUISITION by Lupin Feb 2014
ACQUISITION by Lupin May 2015
ACQUISITION by Lupin Mar 2015
ACQUISITION by Lupin Jul 2008
ACQUISITION by Lupin May 2023